Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by Gustoeson Apr 18, 2019 11:54am
62 Views
Post# 29644914

Global Seborrheic Keratosis - 5-ALA

Global Seborrheic Keratosis - 5-ALA


 

Global Seborrheic Keratosis Market 2019-2025



Key players of the global Seborrheic Keratosis market: Aclaris Therapeutics, Alma Lasers, Angiodynamics, Inc., Apira Science Inc., Becton Dickinson and Company, Biolase Inc., BioLight Technologies LLC., Coherent, Inc., Cutera, Erchonia Corporation, Integra Miltex, IRIDEX Corp., KAI Medical, Lumenis, Quanta Systems S.p.A., Quantumpm, Syneron Medical Ltd., Theralase Inc., THOR Photomedicine, Valeant

I don't remember them being on last years report. They might have been in the 2023 report.

While not important now,,,  this is an example of the spin off markets once tld1433 is approved.



==================

The use of PDT

Photodynamic Therapy is the application of a product called 5-Aminolevulilnic Acid (5-ALA) and its interaction within cells which the use of oxygen and light.

The 5-ALA is applied to the spot to be treated, where it undergoes a reaction in the cells.  This produces photosensitising which works within the cell. ALA causes the skin cells to become sensitive to a certain type of light and when this light is applied it makes the cells slough off and die.  After these damaged cells have been destroyed, new, healthy cells begin to form.

These damaged cells come from solar, or sun damage.  Prolonged periods of sunlight with no protection of the years can lead to uneven, blotchy skin.  If left untreated, these “sun spots” can have far more dangerous repercusions.,

There are currently many practitioners world-wide that encourage  the use of PDT and it is used as an annual preventative measure to treat and inhibit further sun damage.  

Range of conditions for ALA treatment include –

                Non-Hyperkeratotic keratosis

                Seborrheic keratosis

                Cystic acne, acne vulgaris and generally oily skin

                Rosacea

                Hyperplasia

                Large nose pores

                Uneven skin tone

                Etc. 

Bullboard Posts